Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis

BACKGROUND AND AIMS: The serum/plasma proteome was explored for biomarkers to improve the diagnostic ability of CA19-9 in pancreatic adenocarcinoma (PC). METHODS: A Training Set of serum samples from 20 resectable and 18 stage IV PC patients, 54 disease controls (DCs) and 68 healthy volunteers (HVs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, A, Scarlett, C J, Chung, L, Butturini, G, Scarpa, A, Gandy, R, Wilson, S R, Baxter, R C, Smith, R C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920018/
https://www.ncbi.nlm.nih.gov/pubmed/20588270
http://dx.doi.org/10.1038/sj.bjc.6605764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920018/
https://www.ncbi.nlm.nih.gov/pubmed/20588270
http://dx.doi.org/10.1038/sj.bjc.6605764

Ejemplares similares